We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mosquitoes Genetically Modified as Malaria-Blocking Insect Model

By LabMedica International staff writers
Posted on 02 Dec 2015
Print article
Image: Malaria-vector Anopheles stephensi, the Asian mosquito species that can found from Egypt all the way to China, obtains a blood meal from a human host through its pointed proboscis (Photo Courtesy of Jim Gathany / CDC).
Image: Malaria-vector Anopheles stephensi, the Asian mosquito species that can found from Egypt all the way to China, obtains a blood meal from a human host through its pointed proboscis (Photo Courtesy of Jim Gathany / CDC).
Scientists used CRISPR gene editing to create a parasite-resistant strain of Anopheles mosquito capable of rapidly introgressing malaria-blocking genes into a mosquito population through its progeny, ultimately eliminating the insects’ ability to transmit the Plasmodium falciparum parasite to humans. This new model represents a notable advance in the effort to establish an anti-malarial mosquito population, which with further development could help eradicate a disease that sickens millions worldwide each year.

To create this breed, researchers at the University of California at Irvine and San Diego (CA, USA) inserted a DNA element into the germ-line of Anopheles stephensi (a leading malaria vector in Asia) that resulted in the gene, for preventing parasite transmission, being passed on to an astonishing 99.5% of offspring, resulting in near-Mendelian inheritance ratios of the transgene.

“This opens up the real promise that this technique can be adapted for eliminating malaria,” said Anthony James, professor at UCI. For nearly 20 years, the James lab has focused on engineering anti-disease mosquitoes. His anti-dengue fever models have been tested in cage trials in Mexico and in 2012 he helped show that antibodies adapted from immune system of mice can be introduced into mosquitoes to impair pathogen biology. This trait, though, was inherited by only about half of the progeny.

UCSD biologists Ethan Bier and Valentino Gantz working with Drosophila recently announced the development of a new CRISPR-based mutagenic chain-reaction method for generating mutations in both copies of a gene, allowing for germ-line transmission of mutations with 95% inheritance rate. The two groups collaborated to apply Bier and Gantz’s method to James’ mosquitoes. Prof. Gantz packaged antimalaria genes using the DNA-cutting Cas9 enzyme and a guide-RNA to create a genetic cassette that, when injected into a mosquito embryo, targeted a highly specific spot in the germ line DNA to insert the antimalaria antibody genes. To ensure that the element carrying the malaria-blocking antibodies had reached the desired DNA site, the researchers included in the cassette a protein that gave the progeny red fluorescence in the eyes. Amazingly, almost all offspring—99.5%—exhibited this trait.

Further testing will be needed to confirm the efficacy of the antibodies and could eventually lead to field studies. “This is a significant first step,” said James, “We know the gene works. The mosquitoes we created are not the final brand, but we know this technology allows us to efficiently create large populations.” Prof. Bier added, “The ability of this system to carry large genetic payloads should have broad applications to the future use of related Crispr-based ‘active genetic’ systems.”

The study, by Gantz VM et al., was published online ahead of print November 23, 2015, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

University of California, Irvine 
University of California, San Diego 


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.